News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
First-line mFOLFIRINOX for GI high grade neuroendocrine neoplasms, summarized by Erman Akkus
Photo from Erman Akkus/X
May 24, 2024, 14:27

First-line mFOLFIRINOX for GI high grade neuroendocrine neoplasms, summarized by Erman Akkus

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:

“First-line mFOLFIRINOX for GI high-grade neuroendocrine neoplasms?

  • ORR: 77% (complete response: 3%; partial response: 74%)
  • mPFS: 12 months
  • mOS: 20.6 months

Retrospective, n=35.

Prospective clinical trials are needed, may be considered in patients with high tumor burden and who can tolerate.”

First-line mFOLFIRINOX for GI high grade neuroendocrine neoplasms, summarized by Erman AkkusFirst-line mFOLFIRINOX for GI high grade neuroendocrine neoplasms, summarized by Erman Akkus

First-line mFOLFIRINOX for GI high grade neuroendocrine neoplasms, summarized by Erman Akkus

 

Read further.
Source: Erman Akkus/X

Ankara University cancer Erman Akkus First-line mFOLFIRINOX high grade neuroendocrine neoplasms high tumor burden mFOLFIRINOX OncoDaily Oncology Prospective clinical trials
Special Coverage
Blog
Nov 21, 2024, 06:52
Sylvester’s third annual Art is Medicine exhibit's new theme is "The Bridge to Bahia"
Blog
Nov 21, 2024, 06:49
OncoInfluencers to Follow on Social Media: Dr. Melvin L.K. Chua
Blog
Nov 21, 2024, 06:44
Hedley Lewis: Gratitude to all The Cows who participated in the Virgin Active South Africa Ride Joburg
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024
Blog
Nov 20, 2024, 20:38
Franklin Iheanacho: Changing treatment patterns for hepatocellular carcinoma
Insight
Nov 20, 2024, 20:27
HIPEC improves overall survival in recurrent epithelial ovarian cancer
Blog
Nov 20, 2024, 19:12
Medicaid Cancer Foundation at 1Ummah Annual Convention
Insight
Nov 20, 2024, 19:12
Sahar Mansour: Advancing Breast Microcalcification Detection with AI
Blog
Nov 20, 2024, 19:12
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Blog
Nov 20, 2024, 19:12
Virtual tumor board on the management of a patient with Metastatic Squamous NSCLC - IASLC